Study Explores Demand for Psilocybin-Assisted Therapy in U.S.

WEDNESDAY, Sept. 18, 2024 -- The demand for psilocybin-assisted therapy (PSIL-AT) for major depressive disorder (MDD) and treatment-resistant depression (TRD) varies from 24 to 62 percent depending on the eligibility criteria, according to a study...